MaxCyte, Inc.
MXCT
$2.04
-$0.02-0.97%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 19.52% | 6.48% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 19.52% | 6.48% | |||
| Cost of Revenue | -34.37% | 18.31% | |||
| Gross Profit | 38.69% | 2.82% | |||
| SG&A Expenses | 3.98% | -1.96% | |||
| Depreciation & Amortization | 4.02% | -0.10% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.05% | -2.80% | |||
| Operating Income | 4.70% | 8.20% | |||
| Income Before Tax | 3.17% | 8.31% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 3.17% | 8.31% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 3.17% | 8.31% | |||
| EBIT | 4.70% | 8.20% | |||
| EBITDA | 5.45% | 8.80% | |||
| EPS Basic | 3.59% | 8.73% | |||
| Normalized Basic EPS | 3.66% | 8.59% | |||
| EPS Diluted | 3.59% | 8.73% | |||
| Normalized Diluted EPS | 3.66% | 8.59% | |||
| Average Basic Shares Outstanding | 0.38% | 0.42% | |||
| Average Diluted Shares Outstanding | 0.38% | 0.42% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||